pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·4h ago·1 min read
save

Zuckerberg’s Biohub secures $1.8 billion to expand AI-driven virtual cell platform with Meta and Google

Oct 7, 2026·read at Endpoints ↗Positive

Mark Zuckerberg and Priscilla Chan's nonprofit Biohub announced an expansion of its virtual cell initiative, now backed by $1.8 billion in funding.

The new capital comes from a coalition that includes tech giants Meta and Google as well as U.S. government agencies, aiming to develop AI models that can predict cellular behavior and broader biological processes.

The effort builds on Biohub’s existing Imaging Institute in Redwood City and seeks to accelerate drug discovery and basic research by creating computational models of cells.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Zuckerberg's Biohub expands virtual cell effort to $1.8B, with Meta, Google”

read at Endpoints ↗
104 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AGENUS INC

related stories

  • Sep 22Amgen's Phase 3 Sjögren's win; Novartis' $900M radioligand dealEndpoints
  • Sep 9ARPA-H picks UpDoc, Tempus and Atman to build AI tools for heart diseaseEndpoints
  • Apr 23Post-Hoc Live: MAHA, the new Trump CDC pick and RFK's vaccine agendaEndpoints